Results 81 to 90 of about 1,385,084 (219)

Myxoma Virus-Loaded Mesenchymal Stem Cells in Experimental Oncolytic Therapy of Murine Pulmonary Melanoma

open access: yesMolecular Therapy: Oncolytics, 2020
Oncolytic viruses can target neoplasms, triggering oncolytic and immune effects. Their delivery to melanoma lesions remains challenging. Bone-marrow-derived mesenchymal stem cells (MSCs) were shown to be permissive for oncolytic myxoma virus (MYXV ...
Joanna Jazowiecka-Rakus   +9 more
doaj   +1 more source

Stem cell‐based platforms for cancer therapy: Biological mechanisms, therapeutic applications and clinical translation

open access: yesClinical and Translational Discovery, Volume 6, Issue 6, December 2026.
Stem cell platforms offer distinct therapeutic, supportive and research‐enabling applications in oncology. Haematopoietic stem cell transplantation is established for selected haematological malignancies. Engineered MSCs, NSCs and pluripotent stem cell‐derived products remain investigational anticancer platforms.
Ruba Altahla   +5 more
wiley   +1 more source

Intravenous Injections of a Rationally Selected Oncolytic Herpes Virus as a Potent Virotherapy for Hepatocellular Carcinoma

open access: yesMolecular Therapy: Oncolytics, 2019
As a clinical setting in which novel treatment options are urgently needed, hepatocellular carcinoma (HCC) exhibits intriguing opportunities for oncolytic virotherapy.
Yong Luo   +11 more
doaj   +1 more source

p21 promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker [PDF]

open access: yes, 2010
The oncolytic adenovirus dl922-947 replicates selectively within and lyses cells with a dysregulated Rb pathway, a finding seen in > 90% human cancers.
Balkwill, F.R.   +39 more
core   +1 more source

Reframing Natural Killer Cell Biology for Cancer: From Cytotoxic Potential to Context‐Matched Immune States

open access: yesMedComm – Oncology, Volume 5, Issue 4, December 2026.
Natural killer (NK) cells in cancer occupy context‐dependent states shaped by exposure history, tissue adaptation, and tumor ecology. Therapeutic success requires matching NK‐cell products to dominant ecological constraints rather than relying on cytotoxicity alone.
Jinyi Dong   +4 more
wiley   +1 more source

Oncolytic Virus Services

open access: yes
Oncolytic viruses (OV) selectively replicate and kill cancer cells and spread within the tumor, while not harming normal tissue. Besides this direct oncolytic activity, OVs are also very effective at inducing immune responses to themselves and the infected tumor cells.
openaire   +3 more sources

Infant Embryonal CNS Tumors: Molecular Insights and Treatment Considerations for Contemporary Pediatric Neuro‐Oncology

open access: yesPediatric Blood &Cancer, Volume 73, Issue 11, November 2026.
ABSTRACT Background Embryonal tumors comprise the majority of malignant central nervous system (CNS) neoplasms diagnosed in children under 3 years of age. Compared with their counterparts in older children, these tumors exhibit distinct molecular biology and a more aggressive clinical phenotype, while their management is complicated by the heightened ...
Sudarshawn Damodharan   +3 more
wiley   +1 more source

Supplementary Data from Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients

open access: yes, 2022
Supplementary Data from Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in ...
Victoria A. Jennings (9473021)   +29 more
core   +1 more source

TGF-β Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of Rhabdomyosarcoma

open access: yesMolecular Therapy: Oncolytics, 2017
Oncolytic viruses are an emerging class of cancer therapeutics that couple cytotoxicity with the induction of an anti-tumor immune response. Host-virus interactions are complex and modulated by a tumor microenvironment whose immunosuppressive activities ...
Brian Hutzen   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy